Minnesota Oncology Hematology, PA ( Site 8001)

Minneapolis, Minnesota 55404

0 studies enrolling now · 2 studies all time

What they study most

Gastric Neoplasms, Gastroesophageal Junction Adenocarcinoma, Small Cell Lung Cancer (SCLC)

Studies at this site

• Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811) — Completed
• A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604) — Completed